The Europe blood collection devices market is expected to reach US$ 4,089.33 million by 2027 from US$ 2,662.12 million in 2019; it is estimated to grow at a CAGR of 5.6% from 2020 to 2027. The blood collection devices market is growing primarily due to growing number of accidents and trauma cases, rising incidence of infectious diseases, and rising cancer rate in the Europe region. Factors such as risks associated with the blood collection devices damage the growth of the market. Additionally, technological developments in blood collection techniques and products and increasing government initiatives for blood safety are likely to fuel the growth of the blood collection devices market during the forecast period.
Blood collection devices help in safe withdrawal of blood from the donor to perform various diagnostic tests. Needles & syringes, lancets, and other devices are used for arterial and venous blood collection. Arterial blood collection has various advantages such as arterial blood gas sampling, and intraoperative blood salvage.
In the UK,there are four national blood services namely NBS, SNBTS, NIBTS, and WBS. The regulations retain the term blood bank for the laboratories within hospitals that hold, match, and supply blood components to individual patients. Working toward universal access to safe blood and blood products is a part of WHO's cooperation with governments to ensure people-centered health systems that are universal, equitable, sustainable, of high quality, and one of the four policy priorities as of Health 2020, the European health policy framework. WHO/Europe works with national health authorities and international stakeholders and partners for blood-service reform, the development of national donor programmes, quality management of services and products, evidence-based transfusion therapy, enhanced information sharing and the dissemination of WHO guidelines and recommendations promoting the health-system approach. As a participant in the WHO global database on blood safety, WHO/Europe collects data on blood services in the European region to document achievements and reassess strategic directions. These safety strategies implemented by government drives the blood collection devices market in Europe.
TheCOVID-19 outbreak has badly affected the countries such as Italy, Spain, Germany, France, and the UK. Blood donation saves lives and it is majorly required by European countries amidst the COVID-19 pandemic. Majority of the healthcare research institutes and pharmaceutical companies are stepping forward to discover a therapeutic solution for the disease. Companies are now focusing on the development of the antibody-specific COVID-19 blood test. The rising number of blood tests performed for COVID-19 diagnosis is likely to boost the demand for blood collection devices in the region.
Based on product, the blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. In 2019, the blood collection needles/holders segment accounted for the largest share of the blood collection devices market. The growth of this segment attributes to the high adoption of the products in various medical diagnostic and treatment procedures. On the other hand, blood collection tubes are anticipated to witness fastest growth in the market owing to rising number of diseases that demands multiple blood-testing methods and technological advancements in blood collection tubes.
World Health Organization (WHO), National Institute of Health (NHS), National Blood Authority (NBA), World Bank, and European Liquid Biopsy Society (ELBS) are a few of the significant secondary sources associated with the Europe blood collection devices market.
Reasons to Buy
Blood collection devices help in safe withdrawal of blood from the donor to perform various diagnostic tests. Needles & syringes, lancets, and other devices are used for arterial and venous blood collection. Arterial blood collection has various advantages such as arterial blood gas sampling, and intraoperative blood salvage.
In the UK,there are four national blood services namely NBS, SNBTS, NIBTS, and WBS. The regulations retain the term blood bank for the laboratories within hospitals that hold, match, and supply blood components to individual patients. Working toward universal access to safe blood and blood products is a part of WHO's cooperation with governments to ensure people-centered health systems that are universal, equitable, sustainable, of high quality, and one of the four policy priorities as of Health 2020, the European health policy framework. WHO/Europe works with national health authorities and international stakeholders and partners for blood-service reform, the development of national donor programmes, quality management of services and products, evidence-based transfusion therapy, enhanced information sharing and the dissemination of WHO guidelines and recommendations promoting the health-system approach. As a participant in the WHO global database on blood safety, WHO/Europe collects data on blood services in the European region to document achievements and reassess strategic directions. These safety strategies implemented by government drives the blood collection devices market in Europe.
TheCOVID-19 outbreak has badly affected the countries such as Italy, Spain, Germany, France, and the UK. Blood donation saves lives and it is majorly required by European countries amidst the COVID-19 pandemic. Majority of the healthcare research institutes and pharmaceutical companies are stepping forward to discover a therapeutic solution for the disease. Companies are now focusing on the development of the antibody-specific COVID-19 blood test. The rising number of blood tests performed for COVID-19 diagnosis is likely to boost the demand for blood collection devices in the region.
Based on product, the blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, and others. In 2019, the blood collection needles/holders segment accounted for the largest share of the blood collection devices market. The growth of this segment attributes to the high adoption of the products in various medical diagnostic and treatment procedures. On the other hand, blood collection tubes are anticipated to witness fastest growth in the market owing to rising number of diseases that demands multiple blood-testing methods and technological advancements in blood collection tubes.
World Health Organization (WHO), National Institute of Health (NHS), National Blood Authority (NBA), World Bank, and European Liquid Biopsy Society (ELBS) are a few of the significant secondary sources associated with the Europe blood collection devices market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Blood Collection Devices Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the EuropeBlood Collection Devices Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Blood Collection Devices Market - Market Landscape
5. Europe Blood Collection Devices Market - Key Market Dynamics
6. Blood Collection Devices Market - Europe Analysis
7. Europe Blood Collection Devices Market Analysis and Forecasts To 2027 - By Product
8. Europe Blood Collection Devices Market Analysis and Forecasts To 2027 - By Method
9. Europe Blood Collection Devices Market Analysis - By End-User
10. Blood Collection Devices Market Revenue and Forecasts To 2027 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on Europe Blood Collection Devices Market
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Nipro
- BD
- FL MEDICAL s.r.l
- Cardinal Health Inc
- SARSTEDT AG and Co. KG
